08 May 2018 : Clinical Research
Jinfu’an Decoction Inhibits Invasion and Metastasis in Human Lung Cancer Cells (H1650) via p120ctn-Mediated Induction and Kaiso
Zhe SunBCDEF, Yang CaoAEFG, Guangyun HuBCF, Jiuda ZhaoCDF, Ming ChenBC, Sisi WangBF, Zengjie YeCF, Hongyu ChenBD, Wenping WangBE, Ya’nan WangDFDOI: 10.12659/MSM.909748
Med Sci Monit 2018; 24: CLR2878-2886
Abstract
BACKGROUND: Previous research showed that Jin-Fu-An decoction has a significant effect on lung cancer. However, it remains unclear whether p120ctn and its transcription factor Kaiso play a role in lung cancer cell proliferation, adhesion, migration, and metastasis.
MATERIAL AND METHODS: Proliferation inhibition was detected by CCK-8 assay. The migration and invasion were detected using Transwell assay. The location and expression of p120ctn and Kaiso were monitored by immunofluorescence staining. The expression changes of p120ctn, its isoform 1A, its S288 phosphorylation, and Kaiso were measured by Western blot assay.
RESULTS: The lung cancer cell line H1650 administered Jin-Fu-An decoction had significantly reduced the growth in dose-dependent and time-dependent manners. Migration and metastasis were significantly inhibited by application of Jin-Fu-An decoction in a dose-dependent manner. Additionally, Jin-Fu-An decoction decreased the expressions of p120ctn, its isoform 1A, and its S288 phosphorylation, but the protein level of Kaiso was elevated.
CONCLUSIONS: Jin-Fu-An decoction inhibits the proliferation, adhesion, migration, and metastasis though down-regulation of p120ctn or its isoform 1A expression, mediating the up-regulation of Kaiso. The underlying mechanism of Jin-Fu-An decoction might involve targeting the lower expression of p120ctn S288 phosphorylation, which suggests that Jin-Fu-An decoction may be a potential therapeutic measure as prevention and control of recurrence and metastasis of lung cancer.
Keywords: Chinese Medicinal Formula, Invasion and Metastasis, Jinfu’an Decoction, lung cancer, p120ctn and Kasio
Editorial
01 June 2025 : Editorial
Editorial: Harmonization and Publication of the 2025 Updates of the CONSORT and SPIRIT Statements for Clinical TrialsDOI: 10.12659/MSM.949923
Med Sci Monit 2025; 31:e949923
In Press
Clinical Research
Biomarker Discovery in Childhood Asthma: A Pilot Study of Serum Metabolite Analysis for IgE-Dependent AllergyMed Sci Monit In Press; DOI: 10.12659/MSM.948478
Review article
Antitumor Alkaloids in Tibetan Corydalis: Chemical Diversity and Pharmacological InsightsMed Sci Monit In Press; DOI: 10.12659/MSM.947268
Clinical Research
Differentiating Between Methylphenidate Use and Misuse: Clinical Insights From University Students and Acad...Med Sci Monit In Press; DOI: 10.12659/MSM.948984
Clinical Research
Six-Year Outcomes of CABG vs PCI in Diabetic Patients with Multivessel Coronary DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.948348
Most Viewed Current Articles
17 Jan 2024 : Review article 9,080,994
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 704,112
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 32,983
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 27,378
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912